Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 251

2.

Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.

Rifkind BM.

Am J Cardiol. 1984 Aug 27;54(5):30C-34C.

PMID:
6382999
[PubMed - indexed for MEDLINE]
3.

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.

[No authors listed]

JAMA. 1984 Jan 20;251(3):351-64.

PMID:
6361299
[PubMed - indexed for MEDLINE]
4.

The Lipid Research Clinics Coronary Primary Prevention Trial.

Rifkind BM.

Drugs. 1986;31 Suppl 1:53-60.

PMID:
3720571
[PubMed - indexed for MEDLINE]
5.

High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.

Gordon DJ, Knoke J, Probstfield JL, Superko R, Tyroler HA.

Circulation. 1986 Dec;74(6):1217-25.

PMID:
3536151
[PubMed - indexed for MEDLINE]
6.

The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.

Levy RI, Brensike JF, Epstein SE, Kelsey SF, Passamani ER, Richardson JM, Loh IK, Stone NJ, Aldrich RF, Battaglini JW, et al.

Circulation. 1984 Feb;69(2):325-37.

PMID:
6360415
[PubMed - indexed for MEDLINE]
7.

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr.

JAMA. 1998 May 27;279(20):1615-22.

PMID:
9613910
[PubMed - indexed for MEDLINE]
8.

Dietary and other correlates of changes in total and low density lipoprotein cholesterol in hypercholesterolemic men: the lipid research clinics coronary primary prevention trial.

Glueck CJ, Gordon DJ, Nelson JJ, Davis CE, Tyroler HA.

Am J Clin Nutr. 1986 Oct;44(4):489-500.

PMID:
3532756
[PubMed - indexed for MEDLINE]
Free Article
9.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
[PubMed - indexed for MEDLINE]
10.

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.

Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis CE, Abolafia JM, Lippel K, Levy RI.

JAMA. 1994 Apr 6;271(13):999-1003.

PMID:
8139085
[PubMed - indexed for MEDLINE]
11.

Report on the Lipid Research Clinic trials.

Levy RI.

Eur Heart J. 1987 Aug;8 Suppl E:45-53.

PMID:
3315677
[PubMed - indexed for MEDLINE]
12.

Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.

Cai HJ, Li ZX, Yang SM.

Atherosclerosis. 1982 Jun;43(2-3):197-207.

PMID:
7115460
[PubMed - indexed for MEDLINE]
13.

Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group.

Bard JM, Ose L, Hagen E, Duriez P, Pfister P, Fruchart JC, Dallongeville J.

Am J Cardiol. 1995 Jul 13;76(2):65A-70A.

PMID:
7604802
[PubMed - indexed for MEDLINE]
14.
15.

Comparison of treatment with fluvastatin extended-release 80-mg tablets and immediate-release 40-mg capsules in patients with primary hypercholesterolemia.

Isaacsohn JL, LaSalle J, Chao G, Gonasun L.

Clin Ther. 2003 Mar;25(3):904-18.

PMID:
12852707
[PubMed - indexed for MEDLINE]
16.

Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.

Clearfield MB, Weis SE, Willis JM, Vasenius KA, McConathy WJ.

J Am Osteopath Assoc. 2002 Jul;102(7):377-84.

PMID:
12138952
[PubMed - indexed for MEDLINE]
Free Article
17.

The Lipid Research Clinics Coronary Primary Prevention Trial: design, results, and implications.

Probstfield JL, Rifkind BM.

Eur J Clin Pharmacol. 1991;40 Suppl 1:S69-75.

PMID:
2044648
[PubMed - indexed for MEDLINE]
18.

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.

Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, McNamara JR, Kashyap ML, Hershman JM, Wexler LF, Rubins HB; VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein Intervention Trial.

JAMA. 2001 Mar 28;285(12):1585-91.

PMID:
11268266
[PubMed - indexed for MEDLINE]
19.

Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.

Brousseau ME, O'Connor JJ Jr, Ordovas JM, Collins D, Otvos JD, Massov T, McNamara JR, Rubins HB, Robins SJ, Schaefer EJ.

Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1148-54.

PMID:
12117730
[PubMed - indexed for MEDLINE]
Free Article
20.

Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.

Plans-RubiĆ³ P.

Am J Cardiovasc Drugs. 2006;6(3):177-88.

PMID:
16780391
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk